SG Americas Securities’s Kindred Biosciences, Inc. KIN Stock Holding History

SG Americas Securities’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-482,620	Closed	-$4.43M	–	3939
2021 Q2	$4.43M	Buy	+482,620	New	+$2.81M	0.02%	651
2020 Q3	–	Sell	-20,110	Closed	-$90K	–	3759
2020 Q2	$90K	Buy	+20,110	New	+$89.9K	﹤0.01%	3421
2017 Q4	–	Sell	-15,690	Closed	-$123K	–	3796
2017 Q3	$123K	Buy	+15,690	New	+$118K	﹤0.01%	3035

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

SG Americas Securities's KIN Position: Q3 2021 in Review

SG Americas Securities sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 482,620 shares — an estimated $4.43M sold.

SG Americas Securities first reported a position in KIN in Q3 2017 and held it in 3 quarters. The position peaked at $4.43M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

SG Americas Securities reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
SG Americas Securities sold 482,620 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $4.43M.
SG Americas Securities first reported a position in Kindred Biosciences, Inc. in Q3 2017 and held it in 3 quarters.
SG Americas Securities's Kindred Biosciences, Inc. position peaked at $4.43M in Q2 2021.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on SG Americas Securities's 13F filing for Q3 2021, filed 1 Nov 2021.